Please Wait

Applying Filters...

Nepafenac
JDMF
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Nepafenac

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 9 USDMF, 1 JDMF, 6 EU WC, 9 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

FINISHED DOSAGE FORMULATIONS

31 FDF Dossiers, 2 FDA Orange Book, 18 Europe, 2 Canada, 2 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.1%

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Kirsch Pharma, 5 Actylis, 1 Ashland, 2 BASF, 1 Curia, 2 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 1 Keval Exports, 1 Kima Chemical, 5 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 13 Chewable & Orodispersible Aids, 13 Thickeners and Stabilizers, 11 Parenteral, 11 Taste Masking, 10 Direct Compression, 9 Disintegrants & Superdisintegrants, 9 Solubilizers, 5 Co-Processed Excipients, 5 Rheology Modifiers, 4 Topical, 3 Film Formers & Plasticizers, 3 Granulation, 2 Coating Systems & Additives, 1 Emulsifying Agents, 1 API Stability Enhancers

DIGITAL CONTENT

8 News #PharmaBuzz

8 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 7 Regulatory FDF Prices

MARKET PLACE

6 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 4 Health Canada Patents

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	CARBOGEN AMCIS AG	Switzerland	CARBOGEN AMCIS AG	222MF10160	Nepafenac	2010-05-31	2010-05-31	Hauptstrasse 171, CH-4416 Bubendorf, Switzerland

Contact us
to update this info

Nepafenac

Nepafenac

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers

9 USDMF

1 JDMF

6 EU WC

9 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

FINISHED DOSAGE FORMULATIONS

31 FDF Dossiers

2 FDA Orange Book

18 Europe

2 Canada

2 South Africa

7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.3%

SUSPENSION/DROPS;OPHTHALMIC - 0.1%

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

13 SPI Pharma

3 DKSH

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

2 Kirsch Pharma

5 Actylis

1 Ashland

2 BASF

1 Curia

2 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

1 Keval Exports

1 Kima Chemical

5 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders

13 Chewable & Orodispersible Aids

13 Thickeners and Stabilizers

11 Parenteral

11 Taste Masking

10 Direct Compression

9 Disintegrants & Superdisintegrants

9 Solubilizers

5 Co-Processed Excipients

5 Rheology Modifiers

4 Topical

3 Film Formers & Plasticizers

3 Granulation

2 Coating Systems & Additives

1 Emulsifying Agents

1 API Stability Enhancers

DIGITAL CONTENT

8 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

7 Regulatory FDF Prices

MARKET PLACE

6 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents

4 Health Canada Patents